XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.54

-1.2%

11:26 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (4842)	11/23/1997 9:59:00 AM
From: aknahow	Read Replies (1) of 17367

Bob, I have estimated royalty at 2%. Do not think this is too high but of course I have no way of knowing what it will be thus my interest in being able to take out other such income from connetics at least. If we can get a fix on the royalty percent the fact that there will be a ram up to what is now projected as $500,000,000 in potential sales may give us an opportunity to understand the financial impact on XOMA beore the market or better than the market does. At 2% one is looking at $10 million from this one source. Appreciated your insight on impact of FDA changes on trials of drugs for use with children. Do you know if XOMA is presentng at the Robinson Stevens biotech conference in DEc? I have heard but do not know that they will present at the H & Q conference which starts Jan 13. Is this true?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next